DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(1.91) per share which beat the analyst consensus estimate of $(4.90) by 61.02 percent. This is a 46.94 percent increase over losses of $(3.60) per share from the same period last year. The company reported quarterly sales of $5.007 million which missed the analyst consensus estimate of $5.665 million by 11.62 percent. This is a 32.55 percent decrease over sales of $7.423 million the same period last year.